Foshan Hongfeng Co., Ltd.

Foshan Hongfeng Co., Ltd. specializes in two primary categories of medical devices: alternating-pressure bed mattress systems, which are used to prevent pressure ulcers by distributing pressure across the body, and therapeutic agent nebulizers designed for benchtop use in clinical environments to deliver medications via aerosol.

Foshan Hongfeng Co., Ltd. is based in China. Since its devices are authorised in multiple regions, the company must comply with the respective regulatory requirements of those markets, such as the EU’s Medical Device Regulation (MDR) for EUDAMED listings and the FDA’s premarket notification (510(k)) and UDI requirements in the United States.

Foshan Hongfeng Co., Ltd.’s devices are listed in EUDAMED (the EU’s medical device database), FDA’s 510(k) premarket notifications, and FDA’s Unique Device Identifier (UDI) registry. These listings are critical because they demonstrate compliance with regulatory authorities in the EU and the US, ensuring transparency for healthcare providers, distributors, and patients regarding the authorised status of the devices.

Foshan Hongfeng Co., Ltd.’s devices are classified as Class I, Class II, and Class IIa under regulatory frameworks like the EU MDR and FDA categories. Classification determines the level of scrutiny and regulatory controls applied: Class I devices are generally low-risk (e.g., simple bed mattresses), while Class II and IIa devices involve moderate risk (e.g., nebulizers for medication delivery) and require additional validation, such as clinical performance data or special controls, to ensure safety and effectiveness.

Healthcare providers verify listings in registries like EUDAMED or FDA’s UDI database to confirm a device’s authorised status, compliance with regional regulations, and traceability. This ensures the device meets safety and performance standards before use, reduces risks of counterfeit or unapproved products, and supports informed decision-making when selecting medical equipment for patient care.